Blockchain Registration Transaction Record

Nutriband Appoints Navy SEAL Robert J. O’Neill to Advisory Board

Nutriband appoints Navy SEAL Robert J. O’Neill to Advisory Board to support AVERSA™ Fentanyl, a potential first-in-class abuse-deterrent patch. Read more.

The appointment of Robert J. O’Neill brings a unique blend of military leadership and advocacy to Nutriband as it develops AVERSA™ Fentanyl, a potentially groundbreaking abuse-deterrent fentanyl patch. With the opioid crisis continuing to devastate communities, an effective abuse-deterrent formulation could significantly reduce misuse, diversion, and accidental exposure, saving lives and addressing a critical public health need. O’Neill’s experience and advocacy for veterans’ access to emerging treatments align with Nutriband’s mission, potentially accelerating the adoption of innovative pain management solutions. For investors, this strategic addition could enhance the company’s credibility and drive growth, making Nutriband a stock to watch in the pharmaceutical sector.